Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Wockhardt appoints Manas Datta as CFO
Mumbai-based generic drugmaker Wockhardt Ltd has appointed Manas Datta as its chief financial officer (CFO), as per a stock market ......
Healthcare
Sun Pharma to raise up to $2B, may use it for M&As
Sun Pharmaceutical Industries Ltd, the country's most valued pharma company, is aiming to raise as much as $2 billion in ......
Healthcare
Deep Chand Dialysis Centre raising funds from Pragati India Fund
Delhi-based DCDC Health Services Pvt Ltd, which runs dialysis centres under its brand Deep Chand Dialysis Centre (DCDC), has struck ......
Healthcare
Columbia Asia to invest $150M to expand hospital chain in Southeast Asia, India
Columbia Asia, a two-decade-old chain of hospitals headquartered in Malaysia with 27 facilities across India, Malaysia, Vietnam and Indonesia, said ......
Healthcare
Everstone Capital in talks to exit Global Hospitals
Private equity firm Everstone Capital, which had picked significant minority stake in Hyderabad-based Ravindranath GE Medical Associates Ltd, is looking ......
Healthcare
Ascent-backed Alivira to buy 60% stake in Turkish veterinary products firm Provet
Alivira Animal Health Ltd has entered into an agreement to acquire 60 per cent stake in Provet Veterinary Products, Turkey, ......
Healthcare
Apax Partners picks small stake in Strides Arcolab for $8M
Private equity firm Apax Partners has picked up a 1.2 per cent stake in Strides Arcolab, a Bangalore-based pharmaceutical company ......
Healthcare
Fortis Healthcare CFO Sandeep Puri steps down
Sandeep Puri, group CFO of Fortis Healthcare Ltd, the second-largest hospital chain in the country, has resigned from the company, ......
Healthcare
IFC picking 4.4% stake in Vinati Organics
International Finance Corporation (IFC) is picking 4.4 per cent in Vinati Organics by converting its foreign currency convertible bonds (FCCBs) ......
Healthcare
GE Capital clocks almost 2x as Biocon buys back its stake in Syngene for $35M
Drug maker Biocon today acquired GE Capital's entire 7.69 per cent stake in its research services subsidiary Syngene International for ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News